Evaluation of Micropore"s SpiraLith Absorbents

• Status: Completed
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, randomized, double blind study investigating the duration of use and cost of the new CO2 absorbent Micropore's Spiralith®, compared to Drägersorb® 800+, Drägersorb® Free.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rutgers, The State University of New Jersey
• Treatments: Anesthetics; Anesthetics, Inhalation; Calcium, Dietary; Sevoflurane

Criteria

Inclusion Criteria:

• All comers to the 3 designated Operating Rooms.

Exclusion Criteria:

• None